Pizarra, Marvin B.
HRN: 06-21-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
CEFUROXIME 750MG (VIAL)
08/28/2023
09/04/2023
IV
750mg
Q8
UTI
Waiting Final Action
Indication: ProphylaxisEmpiricEmpirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes